Laura Chico
Stock Analyst at Wedbush
(4.79)
# 553
Out of 4,835 analysts
638
Total ratings
52.9%
Success rate
15.6%
Average return
Main Sectors:
Stocks Rated by Laura Chico
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHVS Pharvaris | Reiterated: Buy | $42 → $50 | $37.51 | +33.30% | 9 | Sep 9, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Hold | $30 → $23 | $14.40 | +59.72% | 57 | Sep 3, 2026 | |
| CLYM Climb Bio | Reiterated: Buy | $20 | $14.95 | +33.78% | 7 | Aug 19, 2026 | |
| ARDX Ardelyx | Reiterated: Buy | $19 → $9 | $3.62 | +148.62% | 21 | Aug 18, 2026 | |
| VERA Vera Therapeutics | Reiterated: Hold | $34 | $33.60 | +1.19% | 13 | Aug 17, 2026 | |
| GOSS Gossamer Bio | Reiterated: Hold | $1 | $11.39 | -91.22% | 8 | Aug 14, 2026 | |
| OVID Ovid Therapeutics | Reiterated: Buy | $7 | $2.63 | +166.16% | 13 | Aug 14, 2026 | |
| MAZE Maze Therapeutics | Reiterated: Buy | $48 | $24.82 | +93.39% | 7 | Aug 12, 2026 | |
| JBIO Jade Biosciences | Reiterated: Buy | $47 | $19.14 | +145.56% | 12 | Aug 11, 2026 | |
| SION Sionna Therapeutics | Downgraded: Hold | $53 → $5 | $7.62 | -34.38% | 4 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $20 | $8.29 | +141.25% | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 → $75 | $67.51 | +11.09% | 35 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 → $41 | $22.29 | +83.94% | 74 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $122 | $103.28 | +18.13% | 16 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $11 | $3.85 | +185.71% | 9 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $185 → $194 | $156.57 | +23.91% | 25 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $201 → $215 | $215.43 | -0.20% | 69 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $26 | $21.40 | +21.50% | 27 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $42.90 | +21.21% | 23 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $166 → $162 | $338.57 | -52.15% | 24 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $16 | $9.07 | +76.41% | 8 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $24 | $31.68 | -24.24% | 10 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $4 | $3.02 | +32.45% | 13 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $29.34 | +29.52% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 | $58.80 | +7.14% | 19 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $15.16 | +163.85% | 2 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $7 | $3.19 | n/a | 10 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $11 | $16.75 | n/a | 4 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $14.80 | n/a | 8 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $5 | $5.16 | n/a | 5 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $4.99 | n/a | 4 | Feb 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $45 | $0.8026 | n/a | 5 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $65.51 | n/a | 15 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $514.56 | n/a | 16 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.84 | n/a | 10 | Sep 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.75 | n/a | 4 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $793.26 | n/a | 16 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $8.24 | n/a | 1 | Jan 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.2998 | n/a | 1 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $52.93 | n/a | 1 | Dec 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $1.84 | n/a | 1 | Jun 30, 2017 |
Pharvaris
Sep 9, 2026
Reiterated: Buy
Price Target: $42 → $50
Current: $37.51
Upside: +33.30%
Ultragenyx Pharmaceutical
Sep 3, 2026
Reiterated: Hold
Price Target: $30 → $23
Current: $14.40
Upside: +59.72%
Climb Bio
Aug 19, 2026
Reiterated: Buy
Price Target: $20
Current: $14.95
Upside: +33.78%
Ardelyx
Aug 18, 2026
Reiterated: Buy
Price Target: $19 → $9
Current: $3.62
Upside: +148.62%
Vera Therapeutics
Aug 17, 2026
Reiterated: Hold
Price Target: $34
Current: $33.60
Upside: +1.19%
Gossamer Bio
Aug 14, 2026
Reiterated: Hold
Price Target: $1
Current: $11.39
Upside: -91.22%
Ovid Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $7
Current: $2.63
Upside: +166.16%
Maze Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $48
Current: $24.82
Upside: +93.39%
Jade Biosciences
Aug 11, 2026
Reiterated: Buy
Price Target: $47
Current: $19.14
Upside: +145.56%
Sionna Therapeutics
Aug 10, 2026
Downgraded: Hold
Price Target: $53 → $5
Current: $7.62
Upside: -34.38%
Aug 6, 2026
Reiterated: Buy
Price Target: $21 → $20
Current: $8.29
Upside: +141.25%
Aug 6, 2026
Reiterated: Buy
Price Target: $61 → $75
Current: $67.51
Upside: +11.09%
Aug 6, 2026
Reiterated: Buy
Price Target: $43 → $41
Current: $22.29
Upside: +83.94%
Aug 5, 2026
Reiterated: Buy
Price Target: $105 → $122
Current: $103.28
Upside: +18.13%
Aug 5, 2026
Reiterated: Buy
Price Target: $12 → $11
Current: $3.85
Upside: +185.71%
Aug 3, 2026
Reiterated: Buy
Price Target: $185 → $194
Current: $156.57
Upside: +23.91%
Jul 31, 2026
Reiterated: Hold
Price Target: $201 → $215
Current: $215.43
Upside: -0.20%
Jul 13, 2026
Reiterated: Buy
Price Target: $23 → $26
Current: $21.40
Upside: +21.50%
Jun 17, 2026
Reiterated: Buy
Price Target: $52
Current: $42.90
Upside: +21.21%
Jun 2, 2026
Reiterated: Sell
Price Target: $166 → $162
Current: $338.57
Upside: -52.15%
May 18, 2026
Reiterated: Buy
Price Target: $17 → $16
Current: $9.07
Upside: +76.41%
May 14, 2026
Reiterated: Hold
Price Target: $21 → $24
Current: $31.68
Upside: -24.24%
May 13, 2026
Reiterated: Buy
Price Target: $5 → $4
Current: $3.02
Upside: +32.45%
May 8, 2026
Reiterated: Buy
Price Target: $38
Current: $29.34
Upside: +29.52%
May 8, 2026
Reiterated: Buy
Price Target: $63
Current: $58.80
Upside: +7.14%
May 7, 2026
Reiterated: Buy
Price Target: $40
Current: $15.16
Upside: +163.85%
Aug 7, 2024
Reiterated: Hold
Price Target: $8 → $7
Current: $3.19
Upside: n/a
Apr 11, 2024
Reiterated: Buy
Price Target: $13 → $11
Current: $16.75
Upside: n/a
Mar 20, 2024
Reiterated: Hold
Price Target: $5
Current: $14.80
Upside: n/a
Aug 12, 2022
Reiterated: Buy
Price Target: $22 → $5
Current: $5.16
Upside: n/a
Feb 11, 2022
Reiterated: Buy
Price Target: $23
Current: $4.99
Upside: n/a
Aug 11, 2020
Reiterated: Hold
Price Target: $3 → $45
Current: $0.8026
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $65.51
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $514.56
Upside: n/a
Sep 12, 2018
Downgraded: Hold
Price Target: n/a
Current: $11.84
Upside: n/a
Aug 13, 2018
Reiterated: Hold
Price Target: n/a
Current: $1.75
Upside: n/a
Aug 8, 2018
Reiterated: Hold
Price Target: n/a
Current: $793.26
Upside: n/a
Jan 18, 2018
Initiated Coverage: Buy
Price Target: $24
Current: $8.24
Upside: n/a
Jan 4, 2018
Reiterated: Hold
Price Target: n/a
Current: $0.2998
Upside: n/a
Dec 7, 2017
Reiterated: Buy
Price Target: n/a
Current: $52.93
Upside: n/a
Jun 30, 2017
Reiterated: Buy
Price Target: $30
Current: $1.84
Upside: n/a